We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Autophagy affects hepatic fibrosis progression by regulating macrophage polarization and exosome secretion
Summary
This study found that autophagy regulates hepatic fibrosis progression by controlling macrophage polarization and exosome secretion, which in turn modulates hepatic stellate cell activation.
This study was showed that autophagy could regulate fibrosis by promoting HSC activation by regulating macrophage polarization and exosome secretion.
Sign in to start a discussion.
More Papers Like This
Exosome‐derived miR ‐142‐5p from liver stem cells improves the progression of liver fibrosis by regulating macrophage polarization through CTSB
This paper is not about microplastics; it investigates how exosome-derived microRNA from liver stem cells affects liver fibrosis progression through macrophage regulation.
A bibliometric analysis of autophagy in lung diseases from 2012 to 2021
This bibliometric analysis maps autophagy research in lung diseases from 2012 to 2021, identifying key research hotspots, collaboration networks, and emerging trends linking autophagy mechanisms to various pulmonary conditions.
Reversibility of Renal Fibrosis Induced by Exposure to Polystyrene Nanoplastics: The Dual Role of Lysosomes
Researchers exposed mice to 100 nm and 500 nm polystyrene nanoplastics and examined renal fibrosis, lysosomal function, and autophagy pathways. PS100 induced more pronounced kidney fibrosis than PS500 by impairing lysosomal degradation and disrupting autophagic flux; notably, fibrosis partially reversed after cessation of exposure, suggesting some reversibility in nanoplastic-induced kidney injury.
Acute Endoplasmic Reticulum Stress Induces Inflammation Reaction, Complement System Activation, and Lipid Metabolism Disorder of Piglet Livers: A Proteomic Approach
Researchers used piglet liver models to show that acute endoplasmic reticulum stress triggers a cascade of inflammation, complement system activation, and lipid metabolism disruption, providing proteomic insights relevant to understanding stress-related liver disease mechanisms.
Non-parenchymal cells: key targets for modulating chronic liver diseases
This review examines how specialized non-parenchymal cells in the liver drive chronic liver diseases like fatty liver disease, fibrosis, and cirrhosis through inflammation and scarring. While not directly about microplastics, these are the same cell types and disease pathways that microplastics and nanoplastics have been shown to activate when they accumulate in liver tissue. Understanding these mechanisms helps explain how environmental pollutants like microplastics could contribute to the growing burden of chronic liver disease.